Sumitomo Chemical Company, Limited (FRA:SMM)
Germany · Delayed Price · Currency is EUR | Market Cap | 4.65B +36.2% |
| Revenue (ttm) | 12.70B -10.7% |
| Net Income | 332.44M +57.9% |
| EPS | 0.20 +57.5% |
| Shares Out | n/a |
| PE Ratio | 14.00 |
| Forward PE | n/a |
| Dividend | 0.07 (2.71%) |
| Ex-Dividend Date | Mar 30, 2026 |
| Volume | n/a |
| Open | 2.825 |
| Previous Close | 2.771 |
| Day's Range | 2.823 - 2.829 |
| 52-Week Range | 2.020 - 3.400 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 4, 2026 |
About Sumitomo Chemical Company
Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc. The ICT & Mobility Solutions segment provides optical products, semiconductor processing materials, compound semiconductor materials, touch screen sensor panels, high-purity alum... [Read more]
Financial Performance
In fiscal year 2026, Sumitomo Chemical Company's revenue was 2.33 trillion, a decrease of -10.66% compared to the previous year's 2.61 trillion. Earnings were 60.95 billion, an increase of 57.93%.
Financial numbers in JPY Financial StatementsNews
Sumitomo Chemical Company Earnings Call Transcript: Q4 2026
FY 2025 saw strong recovery with core operating income up JPY 68 billion and net income up JPY 22.4 billion year-over-year. FY 2026 guidance projects further growth, led by Agro & Life Solutions and ICT & Mobility Solutions, with continued portfolio shift and strategic investments in growth areas.
Sumitomo Chemical Company Quarterly report: Q4 2026
Sumitomo Chemical Company has published its Q4 2026 quarterly earnings report on May 14, 2026.
Sumitomo Chemical Company Slides: Q4 2026
Sumitomo Chemical Company has posted slides in relation to its Q4 2026 quarterly earnings report, which was published on May 14, 2026.
Sumitomo Chemical Company Earnings Call Transcript: Q3 2026
Core operating income and net income rose sharply year-on-year, driven by pharma and divestiture gains, despite lower sales revenue. FY2025 guidance was raised, with a higher dividend payout and improved outlook for semiconductors, while non-recurring losses are expected in Q4.
Sumitomo Chemical Company Quarterly report: Q3 2026
Sumitomo Chemical Company has published its Q3 2026 quarterly earnings report on February 3, 2026.
Sumitomo Chemical Company Slides: Q3 2026
Sumitomo Chemical Company has posted slides in relation to its Q3 2026 quarterly earnings report, which was published on February 3, 2026.
Samsung Electro-Mechanics Signs MOU with Sumitomo Chemical Group to Establish a Joint Venture for 'Glass Core' Used in Package Substrates
Strengthening strategic cooperation for next-generation semiconductor package core material 'Glass Core' Aiming to lead the glass substrate market by combining strengths in preparation for the AI era ...
Sumitomo Chemical Company Earnings Call Transcript: Q2 2026
Core operating income and net profit rose sharply year-over-year, led by pharma segment gains and favorable forex, despite lower overall sales revenue. Full-year guidance was raised for core profit, with strong North American pharma sales and improved margins in key materials segments expected to drive results.
Sumitomo Chemical Company Quarterly report: Q2 2026
Sumitomo Chemical Company has published its Q2 2026 quarterly earnings report on November 4, 2025.
Sumitomo Chemical Company Slides: Q2 2026
Sumitomo Chemical Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on November 4, 2025.
Shares of Asian drugmakers drop after Trump threatens tariffs
Shares of Asian drugmakers mostly fell on Friday after U.S. President Donald Trump threatened 100% tariffs on imports of branded pharmaceuticals from October 1, unless their producers had already brok...
Sumitomo Chemical Company Transcript: Status Update
Management is prioritizing core businesses in organic synthesis, crop protection, and advanced materials, while expanding into regenerative medicine and cell therapy. Financial targets include improved capital efficiency and shareholder returns, with ongoing structural reforms and a focus on innovation to stay competitive.
Sumitomo Chemical Company Slides: Status Update
Sumitomo Chemical Company has posted slides in relation to its latest quarterly earnings report, which was published on September 25, 2025.
Sumitomo Chemical Company Earnings Call Transcript: Q1 2026
First quarter FY2025 saw improved core operating income and segment profitability, despite lower sales revenue and a net loss driven by foreign exchange impacts. Outlook for the first half remains positive, with strong shipments and one-time gains expected to support results.
Sumitomo Chemical Company Quarterly report: Q1 2026
Sumitomo Chemical Company has published its Q1 2026 quarterly earnings report on August 1, 2025.
Sumitomo Chemical Company Slides: Q1 2026
Sumitomo Chemical Company has posted slides in relation to its Q1 2026 quarterly earnings report, which was published on August 1, 2025.
Chloroethane Global Market Insights 2025, Analysis and Forecast to 2030, with Profiles of Westlake, Sumitomo Chemical, and Lanxess
Chloroethane Market Growth: Discover trends in the chloroethane market driven by advancements in coatings, plastics, and gasoline additives. This volatile organic compound thrives on high-purity produ...
Middle East and Africa Electric Vehicle Battery Separator Market Forecast Report 2025-2030, with Key Player Profiles for Entek, Toray, Sinoma, UBE, Celgard, Sumitomo Chemical & Abu Dhabi Polymers
Key drivers include rising EV adoption and falling lithium-ion battery costs, with significant growth anticipated in the UAE. Key drivers include rising EV adoption and falling lithium-ion battery cos...
Sumitomo Chemical Company Earnings Call Transcript: Q4 2025
Core operating income rebounded sharply in FY 2024, driven by improved segment performance and asset sales, with net income and free cash flow turning positive. FY 2025 guidance anticipates higher profits despite lower revenue, amid FX and tariff headwinds.
Sumitomo Chemical Company Quarterly report: Q4 2025
Sumitomo Chemical Company has published its Q4 2025 quarterly earnings report on May 14, 2025.
Sumitomo Chemical Company Slides: Q4 2025
Sumitomo Chemical Company has posted slides in relation to its Q4 2025 quarterly earnings report, which was published on May 14, 2025.
Sumitomo Chemical Company Transcript: Status Update
The new business plan targets a V-shaped recovery and sustainable growth by focusing investments and R&D on Agro and ICT, while advancing structural reforms and capital efficiency. Financial targets include JPY 200 billion core operating income by FY 2027 and JPY 350 billion by 2035, with strengthened governance and digital transformation initiatives.
Sumitomo Chemical Company Slides: Status Update
Sumitomo Chemical Company has posted slides in relation to its latest quarterly earnings report, which was published on March 4, 2025.
Sumitomo Chemical Company Earnings Call Transcript: Q3 2025
Q3 FY2024 saw a strong turnaround with core operating income and net income both sharply higher year-on-year, driven by Pharma and ICT & Mobility. Full-year guidance is unchanged, with segment forecasts adjusted for market and operational factors.
Sumitomo Chemical Company Quarterly report: Q3 2025
Sumitomo Chemical Company has published its Q3 2025 quarterly earnings report on February 3, 2025.